Acute joint inflammation in mice after systemic injection of the cell wall, its peptidoglycan, and chemically defined peptidoglycan subunits from various bacteria.
The systemic injection of an aqueous suspension of cell wall or its peptidoglycan (PG)-rich sonicate derived from group A streptococcus and Lactobacillus casei induced acute joint lesions in BALB/c, DBA/1J, (BALB/c X DBA/1J)F1, and C3H/He mouse strains, but not in C57BL/6, DBA/2, and AKR strains. Cell walls and their enzymatically degraded PG fragments from other bacteria as well as the synthetic disaccharide dipeptide and Lactobacillus plantarum cell wall-derived disaccharide tripeptide produced similar acute inflammation in susceptible BALB/c mice. Acute swelling and erythema of the ankles and wrists were observed as early as 3 h, reached maximum severity by day 2, and generally subsided by days 4 to 6 after injection. Histological studies showed synovial proliferation, marked infiltration of many mononuclear cells and a few polymorphonuclear leukocytes in the soft tissues, and extensive deposition of fibrinous exudate in the joint space. Antibody response was detectable against the PG fraction. However, anti-PG antibody does not seem to be responsible for the pathogenesis of this disease. On the other hand, experiments on decomplementation by cobra venom factor suggest that complement components are involved in the early phase of this arthritic model.
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D000942:Antigens, Bacterial / Q000276:immunology*; D001168:Arthritis / Q000276:immunology*; D001419:Bacteria / Q000276:immunology*; D002473:Cell Wall / Q000276:immunology; D003165:Complement System Proteins / Q000378:metabolism; D004187:Disaccharides / Q000276:immunology; D004546:Elapid Venoms / Q000494:pharmacology; D005260:Female; D006020:Glycopeptides / Q000276:immunology; D007780:Lacticaseibacillus casei / Q000276:immunology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010457:Peptidoglycan / Q000276:immunology; D013297:Streptococcus pyogenes / Q000276:immunology; D013329:Structure-Activity Relationship
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D004187:Disaccharides; D004546:Elapid Venoms; D006020:Glycopeptides; D010457:Peptidoglycan; C016310:cobra venom factor; D003165:Complement System Proteins